The FDA has granted accelerated approval to Otarmeni, the first gene therapy for inherited deafness caused by OTOF gene mutations. Clinical trials showed that a single inner-ear injection restored ...
The FDA granted accelerated approval to lunsotogene parvec (Otarmeni) as the first gene therapy for genetic hearing loss, the ...
Live Science on MSN
'A landmark moment for the field': FDA approves first-ever gene therapy for inherited deafness
A gene therapy made by Regeneron is the first treatment of its kind approved for genetic hearing loss.
Otarmeni, now cleared to treat a rare, inherited kind of hearing loss, is the first gene therapy cleared under the FDA’s ...
The FDA has granted an accelerated approval for Otarmeni (lunsotogene parvec-cwha), the first gene therapy to treat patients ...
Australian pharma companies have little to fear from US drug tariffs. But get set for robust negotiations on the PBS and drug ...
Last Wednesday, North Walpole resident Sarah Mills was scrolling through Facebook when a post grabbed her attention.
Ryder Boen, an 11-year-old from Oklahoma, experienced hearing clearly for the first time after receiving a cochlear implant ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Rory Evans Rory Evans is a writer focused on skin-care and beauty products.
Microsoft Defender Security Research has observed a widespread phishing campaign leveraging the device code authentication flow to compromise organizational accounts at scale. While traditional device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results